002737 葵花药业
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额204,291889,6881,975,341865,2291,169,867
投资活动产生之现金流量净额1,006,83236,199(644,430)(889,722)(203,846)
筹资活动产生之现金流量净额(1,016)(1,038,830)(246,565)(309,326)(783,599)
汇率变动对现金及现金等价物的影响(134)232(17)----
现金及现金等价物净增加/(减少)1,209,972(112,712)1,084,329(333,819)182,422
期初现金及现金等价物余额2,285,7052,398,4171,314,0881,647,9071,465,485
期末现金及现金等价物余额3,495,6772,285,7052,398,4171,314,0881,647,907